Study
Pilot Randomized Controlled Trial of Krill Oil Supplementation for Chronic Musculoskeletal Pain in Older Adults.
In a 40-person pilot, krill oil raised the omega-3 index; pain findings were exploratory and not definitive.
Summary Can krill oil reduce long-lasting pain in older adults? Show / hide ↓
Researchers gave 40 adults aged 60 or older with ongoing muscle and joint pain either 4 grams of krill oil daily or a placebo, an inactive look-alike treatment, for 12 weeks. Neither participants nor researchers knew who received which treatment until the study ended. Krill oil increased the omega-3 index, a blood measure of omega-3 fats, from 4.3% to 7.4%, while it barely changed with placebo. Pain results were exploratory, meaning the study was too small to give a firm answer, although some measures favored krill oil. The number of painful areas was lower with krill oil, but other pain findings were uncertain, and no serious side effects occurred.
What this means for you: This study is too small and short to justify buying krill oil for chronic pain. It shows that krill oil raises blood omega-3 levels, but does not prove meaningful pain relief or a longer life.
early evidenceThis 12-week double-blind, randomised, placebo-controlled pilot enrolled 40 community-dwelling adults aged 60 years or older with moderate chronic musculoskeletal pain. Participants received either 4 g/day of krill oil, providing 1,288 mg EPA plus DHA, or placebo. The primary outcomes were feasibility measures rather than pain relief.
Recruitment targets were met within 8 months. Retention was 95%, adherence exceeded 70% in both groups, and acceptability averaged 7.7 out of 10. Krill oil increased the omega-3 index from 4.3% to 7.4%; the placebo group had no meaningful change. Pain outcomes were exploratory. The abstract reports trends favouring krill oil for pain intensity, fewer pain sites and global improvement. The reduction in pain sites had a rate ratio of 0.59, with a 95% confidence interval from 0.41 to 0.84. The global-improvement odds ratio was 4.35, but its 95% confidence interval, 0.97 to 19.55, included no effect. No serious adverse events occurred.
This trial shows that the regimen was feasible and altered omega-3 status. It was not powered as a definitive pain-efficacy study, and it says nothing about longevity.
Krill oil supplementation was feasible and acceptable in older US adults with chronic musculoskeletal pain, supporting a fully powered pain trial.
Only 40 participants were studied for 12 weeks, and feasibility was the primary outcome. The pain results were exploratory, while the global-improvement confidence interval included no effect.
Cited by
1 encyclopedia entries reference this study.